Price T Rowe Associates Inc Abb Vie Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 10,943,208 shares of ABBV stock, worth $2.13 Billion. This represents 0.22% of its overall portfolio holdings.

Number of Shares

10,943,208

Previous 10,744,190 1.85%

Holding current value

$2.13 Billion

Previous $1.96 Billion 4.07%

% of portfolio

0.22%

Previous 0.24%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $30.8 Million - $36 Million	199,018 Added 1.85%	10,943,208 $1.88 Billion
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $206 Million - $235 Million	1,291,201 Added 13.66%	10,744,190 $1.96 Billion
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $463 Million - $521 Million	-3,361,579 Reduced 26.23%	9,452,989 $1.46 Billion
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $46.8 Million - $54.2 Million	-350,146 Reduced 2.66%	12,814,568 $1.91 Billion
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $585 Million - $727 Million	-4,411,166 Reduced 25.1%	13,164,714 $1.77 Billion
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $412 Million - $474 Million	-2,847,220 Reduced 13.94%	17,575,880 $2.8 Billion
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $567 Million - $680 Million	-4,098,236 Reduced 16.71%	20,423,100 $3.3 Billion
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $844 Million - $968 Million	-6,286,462 Reduced 20.41%	24,521,336 $3.29 Billion
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $815 Million - $1.04 Billion	-5,924,329 Reduced 16.13%	30,807,798 $4.72 Billion
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $547 Million - $679 Million	4,146,214 Added 12.72%	36,732,127 $5.95 Billion
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $685 Million - $867 Million	6,377,892 Added 24.34%	32,585,913 $4.41 Billion
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $297 Million - $337 Million	-2,791,314 Reduced 9.63%	26,208,021 $2.83 Billion
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $338 Million - $377 Million	-3,212,860 Reduced 9.97%	28,999,335 $3.27 Billion
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $30.3 Million - $33.4 Million	-296,222 Reduced 0.91%	32,212,195 $3.49 Billion
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $2.62 Billion - $3.53 Billion	32,508,417 New	32,508,417 $3.48 Billion

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Abb Vie Inc. Transaction History